Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Immunotherapeutic approaches for hepatocellular carcinoma	ONCOTARGET	2017
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group	BMC CANCER	2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? (vol 23, pg 2313, 2012)	ANNALS OF ONCOLOGY	2017
Developing drugs in cancer-related bone pain	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale	EUROPEAN JOURNAL OF CANCER	2017
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib	ONCOTARGET	2017
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review	ONCOTARGET	2017
The ‘Charter of Rights for Family Caregivers’. The role and importance of the caregiver: an Italian proposal	ESMO OPEN	2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis	ONCOTARGET	2017
HER2 status in gastric cancer: Comparison between primary and distant metastatic disease	PATHOLOGY ONCOLOGY RESEARCH	2017
Determinants of bone specific metastasis in prostate cancer	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide	CANCER TREATMENT REVIEWS	2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma	BRITISH JOURNAL OF CANCER	2017
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis	SCIENTIFIC REPORTS	2017
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions	ONCOTARGET	2017
Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma	DIGESTIVE DISEASES AND SCIENCES	2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy	THE ONCOLOGIST	2017